首页|Robust neutralization of SARS-CoV-2 variants including JN.1 and BA.2.87.1 by trivalent XBB vaccine-induced antibodies
Robust neutralization of SARS-CoV-2 variants including JN.1 and BA.2.87.1 by trivalent XBB vaccine-induced antibodies
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
万方数据
Xun Wang、Shujun Jiang、Wentai Ma、Yanliang Zhang、Pengfei Wang
展开 >
Shanghai Pudong Hospital,Fudan University Pudong Medical Center,State Key Laboratory of Genetic Engineering,MOE Engineering Research Center of Gene Technology,School of Life Sciences,Shanghai Institute of Infectious Disease and Biosecurity,Fudan University,Shanghai,China
Department of Infectious Diseases,Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine,Nanjing Research Center for Infectious Diseases of Integrated Traditional Chinese and Western Medicine,Nanjing,Jiangsu,China
Beijing Institute of Genomics,Chinese Academy of Sciences,University of Chinese Academy of Sciences and China National Center for Bioinformation,Beijing,China
National Natural Science Foundation of ChinaShanghai Rising-Star ProgramProgram of Science and Technology Cooperation with Hong Kong,Macao,and TaiwanNanjing Research Center for Infectious Diseases of Integrated Traditional Chinese and Western MedicineNATCM's Project of Highlevel Construction of Key TCM DisciplinesAl for Science project of Fudan UniversityOpen Research Fund of State Key Laboratory of Genetic Engineering,Fudan UniversityXiaomi Young Talents Program
NETL
NSTL
万方数据
